US FDA approves Citius blood cancer therapy
The U.S. Food and Drug Administration has approved Citius Pharmaceuticals The company said Thursday that its blood cancer drug Lymphir is for patients with a relapse who have received at least one prior treatment.
ENTRADAS POPULARES
Poland prepares for peaking floods
septiembre 20, 2024
Italy evacuates thousands as Boris hits the north
septiembre 20, 2024
China and the US race to tame nuclear fusion for clean energy
septiembre 20, 2024
TRANSMISIÓN EN VIVO